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FIGURE 3: People who do not receive anti-cancer 
treatment had lower risk of unplanned admissions for 
respiratory complications when assessed early.
CONCLUSION
People with lung cancer experience physical and emotional hardships, often heightened by low survival rates and side effects of treatments. People may be 
admitted for unplanned hospital care due to reasons related to their lung cancer diagnosis, presenting an economic burden on healthcare resources. For 
individuals, unplanned admissions present a burden on their life that may be avoided through alternative care management initiatives.
Lung cancer nurse specialists (LCNS) are advanced practitioners providing continuity of care across the lung cancer pathway, offering unique expertise within 
multidisciplinary settings and meeting complex patient needs. Small studies support the role of the LCNS in advocating treatment and suggest productivity 
gains through reduced emergency admissionsA.
Lack of specialist cancer workforce resource is a potential barrier to delivering the Cancer Strategy for the UKB. To provide an evidence base for workforce 
policies, we use linkages to the National Lung Cancer Audit (NLCA) to assess whether LCNS working practices contributed to patient outcomes.
FIGURE 1: Chemotherapy and radiotherapy patients had a 
lower risk of death where particular LCNS practices confirmed.
FIGURE 2: Patients had lower risk of emergency cancer 
admissions where LCNS assessed people early, were 
confident in MDT or provided proactive management.
Outcomes were not frequently associated with differences in LCNS working practices but important relationships were observed. Practices were associated 
with at least one positive outcome within each treatment pathway, most notably for those receiving radiotherapy or not receiving anti-cancer therapy. 
Where outcomes were worse, this may be due to greater health awareness or inefficient communication routes. Pathway management could be improved 
through opportunities for proactive LCNS-led clinics and engaging MDT cultures. These findings offer valuable intelligence about LCNS services, the impact 
of which is a challenge to distinguish with current metrics, and will contribute to a growing number of resources informing workforce policy.
: association at p<0.05
: association following 10% False Discovery 
Rate correction for multiple comparisons
*
*
95% confidence interval plotted
Lower risk        no difference        higher risk
< >
: association at p<0.05
: association following 10% False Discovery 
Rate correction for multiple comparisons
*
*
95% confidence interval plotted
Lower risk        no difference        higher risk
< >
: association at p<0.05
: association following 10% False Discovery 
Rate correction for multiple comparisons
*
*
95% confidence interval plotted
Lower risk        no difference        higher risk
< >
Post-diagnosis admissions for cancer, including metastasis, may be influenced by 
timing of LCNS assessments and effective channels to communicate concerns  
Mortality findings may be influenced by the prehabilitative role of LCNS and support 
around treatment decisions, advocating at MDT and meeting information needs
Fewer respiratory admissions in people who did not receive treatment may be 
influenced by advanced care planning and early integration of palliative care
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